VEXAS综合征中18F-FDG-PET/CT异常谱及意义
该多中心回顾性研究分析了66例基因确诊VEXAS综合征患者的125次18F-FDG-PET/CT,发现骨髓(83%)和淋巴结(53%)异常摄取最常见,活动期异常器官数显著高于缓解期(中位2 vs 1,P<0.001),但90%临床缓解期扫描仍存在持续异常,尤以骨髓(57%)为著。
要点
- VEXAS综合征中PET/CT异常常见但非特异,骨髓和淋巴结最常受累。
- 活动期异常器官数显著多于缓解期,但缓解期多数扫描仍有持续异常。
- 骨髓持续高代谢可能提示亚临床疾病活动,PET/CT或可用于疾病监测。
核心结论
- 18F-FDG-PET/CT在VEXAS综合征中显示频繁但非特异性异常,骨髓持续高代谢提示亚临床疾病活动。
- PET/CT诊断价值有限,但可能用于疾病监测。
研究设计与样本
- 多中心回顾性观察性研究,纳入66例基因确诊VEXAS综合征患者,分析125次18F-FDG-PET/CT扫描。
- 定性解读基于当地核医学报告,按疾病活动度、骨髓增生异常综合征状态和死亡率分析。
主要发现
- 骨髓(83%)和淋巴结(53%)是最常见的异常FDG摄取部位。
- 常见组合模式为骨髓、肺、淋巴结和脾脏;肺(38%)和血管(11%)受累也有观察。
- 活动期患者异常FDG摄取器官数显著高于缓解期(中位2 vs 1,P<0.001)。
- 90%临床缓解期扫描显示持续异常,尤其是骨髓(57%)。
临床怎么用
- PET/CT异常在VEXAS中常见但非特异,诊断时需结合基因检测和临床。
- 骨髓持续高代谢可能反映亚临床活动,可考虑用于疾病监测。
局限性
- 回顾性设计,定性解读基于当地核医学报告,可能存在异质性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: VEXAS syndrome (vacuoles, E1 enzyme, X-linked, autoinflammatory, somatic) is a recently identified adult-onset autoinflammatory disorder caused by somatic mutations in UBA1. It is characterized by heterogeneous inflammatory and haematological manifestations, making diagnosis challenging. 18F-FDG-PET/CT imaging, which identifies metabolic activity associated with inflammation and malignancy, is often performed during the diagnostic work-up. However, its utility in VEXAS syndrome remains unclear. METHODS: We conducted a multicentre retrospective observational study of patients with genetically-confirmed VEXAS syndrome who underwent 18F-FDG-PET/CT imaging. Clinical, laboratory and imaging data were collected, and 18F-FDG-PET/CT findings were analysed according to disease activity, myelodysplastic syndrome status and mortality. Qualitative 18F-FDG-PET/CT interpretations were based on local nuclear medicine reports. RESULTS: A total of 125 18F-FDG-PET/CT scans were analysed in 66 patients. Bone marrow (83%) and lymph nodes (53%) were the most frequent sites of abnormal FDG uptake, with combinations of bone marrow, lungs, lymph nodes and spleen being the most common patterns. Pulmonary (38%) and vascular involvement (11%) were also observed. The number of organs with abnormal FDG uptake was significantly higher in patients with active disease compared with remission (median 2 vs 1 abnormal sites, P < 0.001). However, 90% of scans performed during presumed clinical remission showed persistent abnormalities, especially in the bone marrow (57%). CONCLUSION: 18F-FDG-PET/CT imaging reveals frequent but non-specific abnormalities in VEXAS syndrome, with persistent bone marrow hypermetabolism suggesting subclinical disease activity. While 18F-FDG-PET/CT may have limited diagnostic utility, it holds potential for disease monitoring.
引用
- Betrains A, Jachiet V, Dieudonné Y, et al. Spectrum and significance of 18F-FDG-PET/CT abnormalities in VEXAS syndrome. Rheumatology (Oxford). 2026. PMID: 41999206. doi:10.1093/rheumatology/keag194
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。